The Claim
Higher baseline plasma levels of erythritol and erythronate are associated with increased 10-year atherosclerotic cardiovascular disease risk scores in adults with overweight and obesity, with each standard deviation increase in erythritol linked to a 1.1% higher risk estimate after adjusting for BMI.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Adults with overweight or obesity who have higher levels of erythritol and erythronate in their blood have higher calculated 10-year risks of developing atherosclerotic cardiovascular disease, and each standard deviation increase in erythritol corresponds to a 1.1% increase in this risk estimate after accounting for body mass index.
See the scientific wording
Higher baseline plasma levels of erythritol and erythronate are associated with increased 10-year atherosclerotic cardiovascular disease risk scores in adults with overweight and obesity, with each standard deviation increase in erythritol linked to a 1.1% higher risk estimate after adjusting for BMI.
High levels of erythritol and erythronate in the blood damage the inner lining of blood vessels, trigger inflammation, and make it easier for fatty deposits to build up in artery walls, increasing the chance of heart disease.
What the research says
1 studyPeople with more erythritol in their blood at the start were more likely to have a higher risk of heart disease over 10 years, even if they were overweight — and when their erythritol levels went down after dieting, their heart risk improved too.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.